Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Famotidine vs pantoprazole and risk of ventilator-associated pneumonia in ICU
IRCT20231220060484N2Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of famotidine and pantoprazole in ventilator-associated pneumonia (VAP) (2 arms), sponsored by Islamic Azad University. Primary endpoints: Incidence of ventilator-associated pneumonia and Severity of ventilator-associated pneumonia. Started May 2024; status: completed.
02
Drugs
famotidinepantoprazole
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on IRCT20231220060484N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231220060484N2.